Pharma Plus Mali, S.a. Pharmaceutical Import Profile — Mali (DGFT 2022–2026)

Name: Pharma Plus Mali, S.a. Pharmaceutical Import Records from India — 3 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharma Plus Mali, S.a. — Pharmaceutical Importer Profile (2026) | 3 Products, $1.1M Trade | TransData Nexus

Pharma Plus Mali, S.a.

Pharmaceutical Importer · Mali · Antifungals Focus · $1.1M Total Trade · DGFT Verified

Pharma Plus Mali, S.a. is a pharmaceutical importer based in Mali with a total trade value of $1.1M across 3 products in 3 therapeutic categories. Based on 22 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharma Plus Mali, S.a. sources from 2 verified Indian suppliers, with Caplin Point Laboratories Limited accounting for 77.0% of imports.

Pharma Plus Mali, S.a. — Import Portfolio & Supplier Network

Pharma Plus Mali, S.a. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharma Plus Mali, S.a.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$3.7M	169	77.0%
Kwality Pharmaceuticals Limited	$1.1M	208	23.0%

Pharma Plus Mali, S.a. sources from 2 verified Indian suppliers across .

What Formulations Does Pharma Plus Mali, S.a. Import?

Formulation	Value	Ships
Artesunate injection 120MG	$244.2K	8
Artesunate injection 60MG	$225.1K	7
Atorcap (atorvastatin tablets 20MG)	$206.4K	5
Flucap (fluconazole USP 150MG)	$156.0K	5
Gastromag suspension 200ML	$149.9K	5
Arcet suspension (paracetamol oral	$145.9K	5
Artemether + lumefantrine tablets	$140.1K	4
Calben ( albendazole chewable tablets	$137.4K	5
Caplin-caprazole -dsr capsules	$131.8K	5
Caplin - metrowin 500 ovule	$126.2K	3
Ibuprofen tablets BP 800MG tilol -	$114.2K	3
Caplin-cary -250 (erythromycin for	$104.6K	3
Arthel (artemether and lumefantrine	$95.2K	3
Arcet ( paracetamol intravenous infusion) arcet (paracetamol perfusion intraveineuse 1% w/v) 100ML item code	$90.3K	2
Calben oral suspension (albendazole	$87.8K	3

Pharma Plus Mali, S.a. imports 248 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Fluconazole	Antifungals	$500.0K	10	0.5%	3
2	Albendazole	Antimalarial & Antiparasitic	$450.0K	9	0.6%	3
3	Erythromycin	Antibiotics	$150.0K	3	0.2%	11

Pharma Plus Mali, S.a. imports 3 pharmaceutical products across 3 categories into Mali totaling $1.1M.

Pharma Plus Mali, S.a. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharma Plus Mali, S.A., established in 2003, is a leading pharmaceutical wholesaler and distributor based in Bamako, Mali. The company specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Over the years, Pharma Plus Mali has become a trusted partner for healthcare professionals in Mali, offering a comprehensive range of pharmaceutical products and services.

The company's headquarters are located at Lafiabougou Cité ATEPA Villa K 15, Bamako, Mali. Pharma Plus Mali operates as a privately held entity and employs between 201 and 500 individuals. Its strategic partnerships with reputable Indian pharmaceutical manufacturers, such as Caplin Point Laboratories Limited and Kwality Pharmaceuticals Limited, have enabled it to build a robust distribution network across Mali.

2Distribution Network

Pharma Plus Mali's distribution network is centered in Bamako, the capital city of Mali, where its main warehouse is situated. The company has developed an efficient logistics system to ensure timely delivery of pharmaceutical products throughout Mali. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's partnerships with established Indian suppliers suggest a well-organized supply chain capable of meeting the demands of the Malian market.

3Industry Role

As a primary wholesaler and distributor, Pharma Plus Mali plays a crucial role in Mali's pharmaceutical supply chain. The company imports a diverse range of finished pharmaceutical formulations from India, including antifungals, antimalarial and antiparasitic agents, and antibiotics. By sourcing these products from reputable manufacturers, Pharma Plus Mali ensures the availability of essential medications to healthcare providers across the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharma Plus Mali, S.a.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Pharma Plus Mali's sourcing strategy is highly concentrated, with a significant portion of its pharmaceutical imports originating from two Indian suppliers: Caplin Point Laboratories Limited and Kwality Pharmaceuticals Limited. In 2022, Caplin Point Laboratories Limited accounted for 77% of the total import value, while Kwality Pharmaceuticals Limited contributed 23%. This concentration indicates a strategic choice to maintain strong relationships with these suppliers, ensuring consistent product quality and supply reliability. However, such dependency also poses a risk; any disruptions in the supply chain from these suppliers could impact Pharma Plus Mali's ability to meet market demand. The company's diversified product portfolio, with 248 unique formulations, may help mitigate some of these risks by allowing flexibility in sourcing alternative products if necessary.

2Supply Chain Resilience

Pharma Plus Mali's supply chain resilience is influenced by its reliance on two primary Indian suppliers. While this focus allows for streamlined operations and potentially better pricing, it also exposes the company to risks associated with supply chain disruptions, such as production delays or geopolitical issues affecting trade routes. The company's importation of 248 unique formulations suggests a level of diversification that could provide some flexibility in sourcing alternative products if needed. Additionally, the established partnerships with reputable suppliers like Caplin Point Laboratories Limited and Kwality Pharmaceuticals Limited may offer some assurance regarding product quality and regulatory compliance. Nonetheless, Pharma Plus Mali should consider strategies to further diversify its supplier base to enhance supply chain resilience.

Importing Pharmaceuticals into Mali — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Mali

1Regulatory Authority & Framework

In Mali, the regulatory authority overseeing pharmaceutical imports and distribution is the Ministry of Health and Social Affairs. The key legislation governing pharmaceutical imports includes the Public Health Code, which outlines the requirements for the importation, distribution, and sale of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining approval from the Ministry of Health, which assesses the safety, efficacy, and quality of the products. Compliance with these regulations is mandatory for all pharmaceutical imports to ensure public health and safety.

2Import Licensing & GMP

Import licensing requirements in Mali stipulate that all pharmaceutical products must be registered with the Ministry of Health before importation. Manufacturers must provide evidence of Good Manufacturing Practice (GMP) certification, such as EU GMP, WHO GMP, or PIC/S, to demonstrate compliance with international quality standards. Additionally, wholesalers like Pharma Plus Mali must obtain a wholesale distribution authorization from the Ministry of Health, ensuring that they operate in accordance with national regulations and maintain the integrity of the pharmaceutical supply chain.

Quality & Labeling

Pharma Plus Mali, S.a. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Pharma Plus Mali's focus on importing antifungals, antimalarial and antiparasitic agents, and antibiotics aligns with the prevalent health challenges in Mali. The high incidence of infectious diseases such as malaria, fungal infections, and bacterial infections drives the demand for these therapeutic categories. By prioritizing these products, Pharma Plus Mali addresses critical healthcare needs and positions itself as a key supplier of essential medications in the Malian market.

2Sourcing Profile

Pharma Plus Mali's sourcing strategy emphasizes the importation of generic drugs, particularly from India, known for its robust pharmaceutical manufacturing sector. The company's preference for finished pharmaceutical formulations allows for a diverse product portfolio, catering to various therapeutic needs. This approach enables Pharma Plus Mali to offer cost-effective solutions to the Malian healthcare system while maintaining product quality and efficacy.

3Market Positioning

Pharma Plus Mali serves multiple segments of the Malian pharmaceutical market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. Its comprehensive product range and efficient distribution network enable it to meet the diverse needs of healthcare providers across the country. By maintaining strong relationships with both suppliers and customers, Pharma Plus Mali reinforces its position as a leading pharmaceutical distributor in Mali.

Seller's Guide — How to Become a Supplier to Pharma Plus Mali, S.a.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Pharma Plus Mali, especially if they can offer a diverse range of high-quality pharmaceutical formulations that align with the company's existing product portfolio. Identifying gaps in Pharma Plus Mali's current sourcing, such as unmet therapeutic needs or emerging health challenges, could present avenues for introducing new products. Establishing a reliable supply chain and ensuring compliance with Mali's regulatory standards will be crucial for successful market entry.

2Requirements & Qualifications

Indian exporters seeking to supply Pharma Plus Mali must ensure that their products are registered with the Ministry of Health in Mali and possess valid GMP certifications recognized by international bodies such as the EU, WHO, or PIC/S. Additionally, compliance with Mali's labeling requirements, including French language specifications, and adherence to serialization mandates are essential. Demonstrating a commitment to quality and regulatory compliance will enhance the prospects of establishing a successful partnership with Pharma Plus Mali.

3How to Approach

Frequently Asked Questions — Pharma Plus Mali, S.a.

What products does Pharma Plus Mali, S.a. import from India?

Pharma Plus Mali, S.a. imports 3 pharmaceutical products across 3 categories. Top imports: Fluconazole ($500.0K), Albendazole ($450.0K), Erythromycin ($150.0K).

Who supplies pharmaceuticals to Pharma Plus Mali, S.a. from India?

Pharma Plus Mali, S.a. sources from 2 verified Indian suppliers. The primary supplier is Caplin Point Laboratories Limited (77.0% of imports, $3.7M).

What is Pharma Plus Mali, S.a.'s total pharmaceutical import value?

Pharma Plus Mali, S.a.'s total pharmaceutical import value from India is $1.1M, based on 22 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharma Plus Mali, S.a. focus on?

Pharma Plus Mali, S.a. imports across 3 categories. The largest: Antifungals (45.5%), Antimalarial & Antiparasitic (40.9%), Antibiotics (13.6%).

Get Full Pharma Plus Mali, S.a. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.